2012 最新全球在研抗癌新药报告
2012年5月31日,美国PhRMA发布2012年最新全球在研抗癌新药报告
2012 Reports
Medicines in Development Cancer
More Than 900 Medicines and Vaccines in Clinical Testing Offer New Hope in the FightAgainst Cancer
Nearly 1,000 Medicines in Development to Help Patients in Their Fight Against Cancer
Washington, D.C. (May 31, 2012)— America’s biopharmaceutical research companies are testing 981 medicines and vaccines to fight the many types of cancer affecting millions of patients worldwide, according to a report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA). These potential medicines, which are either in clinical trials or under review by the Food and Drug Administration, include 121 for lung cancer, 117 for lymphoma and 111 for breast cancer. |